All News #Library
Others
ImmPACT Bio`s IND For MS CAR-T Therapy Cleared By FDA
21 Aug 2024 //
PR NEWSWIRE
ImmPACT Bio To Present MS CAR-T Preclinical Data
21 May 2024 //
PR NEWSWIRE
ImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer
13 Sep 2022 //
PRNEWSWIRE
ImmPACT Bio Names Sylvain Roy as Chief Technology Officer
10 May 2022 //
PRNEWSWIRE
Novartis-backed ImmPACT Bio $111M ex-Baxter, Pfizer exec new CEO
19 Jan 2022 //
FIERCEBIOTECH

Market Place
Sourcing Support